We are live on ! Find out more
GLSI icon

Greenwich LifeSciences

51 hedge funds and large institutions have $12.1M invested in Greenwich LifeSciences in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

8% more capital invested

Capital invested by funds: $11.2M → $12.1M (+$909K)

0% more funds holding

Funds holding: 5151 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.31% less ownership

Funds ownership: 9.21%8.91% (-0.31%)

Holders
51
Holders Change
Holders Change %
0%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
16
Reduced
14
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$3.61M -$43.8K -3,882 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.81M +$149K +13,179 +5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.41M +$35.4K +3,134 +2%
State Street
4
State Street
Massachusetts
$815K -$3.4K -301 -0.4%
Northern Trust
5
Northern Trust
Illinois
$755K -$77.6K -6,874 -8%
Renaissance Technologies
6
Renaissance Technologies
New York
$382K +$125K +11,100 +41%
Marshall Wace
7
Marshall Wace
United Kingdom
$319K -$272K -24,091 -43%
Deutsche Bank
8
Deutsche Bank
Germany
$214K +$243K +21,502 New
Citadel Advisors
9
Citadel Advisors
Florida
$208K +$81K +7,174 +52%
SO
10
STRS Ohio
Ohio
$199K
Goldman Sachs
11
Goldman Sachs
New York
$197K +$37.8K +3,347 +20%
Charles Schwab
12
Charles Schwab
California
$189K -$530 -47 -0.2%
Millennium Management
13
Millennium Management
New York
$154K -$211K -18,683 -55%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$151K +$6K +532 +4%
RhumbLine Advisers
15
RhumbLine Advisers
Massachusetts
$91.2K +$2.17K +192 +2%
Morgan Stanley
16
Morgan Stanley
New York
$86.8K -$34.4K -3,045 -26%
Barclays
17
Barclays
United Kingdom
$86.7K -$21.1K -1,868 -18%
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$59.7K
Bank of America
19
Bank of America
North Carolina
$48.5K -$4.1K -363 -7%
UBS Group
20
UBS Group
Switzerland
$40.9K +$25.5K +2,261 +123%
Wells Fargo
21
Wells Fargo
California
$37.2K +$6.69K +593 +19%
Mirae Asset Global ETFs Holdings
22
Mirae Asset Global ETFs Holdings
Hong Kong
$29.6K -$5.71K -506 -15%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$28.5K -$2.01K -178 -6%
PFSRSONJ
24
Police & Firemen's Retirement System of New Jersey
New Jersey
$27.5K
JP Morgan Chase
25
JP Morgan Chase
New York
$25.3K -$3.83K -339 -12%

GLSI Hedge Fund Activity: Q3 2025 in Review

51 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2025, worth a combined $12.1M — up 8.1% from $11.2M a quarter earlier.

Fund positioning in GLSI was balanced in Q3 2025: 5 funds opened new positions, 5 closed out, 16 added to existing stakes and 14 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $243K. The largest seller was Marshall Wace, cutting an estimated $272K.

  • 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $12.1M of Greenwich LifeSciences stock for Q3 2025, up 8.1% quarter-over-quarter.
  • 5 funds opened new Greenwich LifeSciences positions in Q3 2025 and 5 closed out, a net change of 0 holders.
  • The largest Greenwich LifeSciences buyer in Q3 2025 was Deutsche Bank, an estimated $243K added.
  • The largest Greenwich LifeSciences seller in Q3 2025 was Marshall Wace, an estimated $272K sold.

Based on aggregated 13F filings for Q3 2025.